The higher sensitivity of PSMA-based PET when compared with the CIMs caused the earlier detection of metastases among the PCa patients, leading to a stage transition from nmCRPC to mCRPC in almost half of the patients (Fendler et al., 2019b; Weber et al., 2021). This evidence concerns the gene FOLH1 and posterior cortical atrophy.